Published in J Chem Inf Model on June 04, 2014
GlyTouCan 1.0 - The international glycan structure repository. Nucleic Acids Res (2015) 0.85
GlycoRDF: an ontology to standardize glycomics data in RDF. Bioinformatics (2014) 0.83
A Knowledge-Based System for Display and Prediction of O-Glycosylation Network Behaviour in Response to Enzyme Knockouts. PLoS Comput Biol (2016) 0.77
Property Graph vs RDF Triple Store: A Comparison on Glycan Substructure Search. PLoS One (2015) 0.77
Glycosaminoglycanomics: where we are. Glycoconj J (2016) 0.77
SugarBindDB, a resource of glycan-mediated host-pathogen interactions. Nucleic Acids Res (2015) 0.76
The Virtual Screening of the Drug Protein with a Few Crystal Structures Based on the Adaboost-SVM. Comput Math Methods Med (2016) 0.75
Many InChIs and quite some feat. J Comput Aided Mol Des (2015) 0.75
Automatic generation of bioinformatics tools for predicting protein-ligand binding sites. Bioinformatics (2015) 0.75
Internet Databases of the Properties, Enzymatic Reactions, and Metabolism of Small Molecules-Search Options and Applications in Food Science. Int J Mol Sci (2016) 0.75
GLYDE-II: The GLYcan data exchange format. Perspect Sci (Neth) (2016) 0.75
From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res (2006) 44.35
KEGG as a glycome informatics resource. Glycobiology (2005) 11.05
Network-based analysis and characterization of adverse drug-drug interactions. J Chem Inf Model (2011) 7.92
Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response. Nat Genet (2007) 4.24
Modular architecture of metabolic pathways revealed by conserved sequences of reactions. J Chem Inf Model (2013) 3.58
Target site specificity of the Tos17 retrotransposon shows a preference for insertion within genes and against insertion in retrotransposon-rich regions of the genome. Plant Cell (2003) 3.45
E-zyme: predicting potential EC numbers from the chemical transformation pattern of substrate-product pairs. Bioinformatics (2009) 2.88
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem (2007) 2.44
Gli2 trafficking links Hedgehog-dependent activation of Smoothened in the primary cilium to transcriptional activation in the nucleus. Proc Natl Acad Sci U S A (2009) 2.43
Comprehensive analysis of glycosyltransferases in eukaryotic genomes for structural and functional characterization of glycans. Carbohydr Res (2009) 2.40
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology (2003) 2.38
Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics (2010) 2.14
Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics (2008) 2.09
Gene annotation and pathway mapping in KEGG. Methods Mol Biol (2007) 2.09
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med (2007) 1.89
ProMode: a database of normal mode analyses on protein molecules with a full-atom model. Bioinformatics (2004) 1.89
Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol (2008) 1.65
Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci (2007) 1.64
STAM proteins bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif. Mol Biol Cell (2003) 1.63
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med (2008) 1.60
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology (2005) 1.49
PathPred: an enzyme-catalyzed metabolic pathway prediction server. Nucleic Acids Res (2010) 1.49
C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood (2013) 1.45
Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics (2009) 1.45
Song memory in female birds: neuronal activation suggests phonological coding. Neuroreport (2010) 1.43
Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J Orthop Res (2004) 1.43
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia. J Clin Psychopharmacol (2015) 1.42
UniCarbKB: building a knowledge platform for glycoproteomics. Nucleic Acids Res (2013) 1.40
The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic data. Mol Cell Proteomics (2013) 1.34
Lectin microarray analysis of pluripotent and multipotent stem cells. Genes Cells (2010) 1.31
Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10). J Mol Biol (2006) 1.31
Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res (2008) 1.31
Drug target prediction using adverse event report systems: a pharmacogenomic approach. Bioinformatics (2012) 1.27
A novel strategy for mammalian cell surface glycome profiling using lectin microarray. Glycobiology (2007) 1.27
A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep (2013) 1.27
Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation. Proc Natl Acad Sci U S A (2007) 1.27
Glycoconjugate microarray based on an evanescent-field fluorescence-assisted detection principle for investigation of glycan-binding proteins. Glycobiology (2008) 1.25
Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int (2005) 1.23
Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci U S A (2005) 1.19
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain. Biochem Biophys Res Commun (2006) 1.19
UniCarbKB: putting the pieces together for glycomics research. Proteomics (2011) 1.17
Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification. Mol Cell Proteomics (2008) 1.16
Molecular phylogeny and new taxa in the Archaeosporales (Glomeromycota): Ambispora fennica gen. sp. nov., Ambisporaceae fam. nov., and emendation of Archaeospora and Archaeosporaceae. Mycol Res (2007) 1.15
Molecular cloning and characterization of a novel human beta1,3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domain. Glycobiology (2006) 1.15
Cellulose complementing factor (Ccp) is a new member of the cellulose synthase complex (terminal complex) in Acetobacter xylinum. J Biosci Bioeng (2013) 1.15
Toolboxes for a standardised and systematic study of glycans. BMC Bioinformatics (2014) 1.15
MIRAGE: the minimum information required for a glycomics experiment. Glycobiology (2014) 1.14
Structural insight into the mitochondrial protein import system. Biochim Biophys Acta (2010) 1.14
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. J Hepatol (2004) 1.13
Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10. FEBS Lett (2002) 1.12
BioHackathon series in 2011 and 2012: penetration of ontology and linked data in life science domains. J Biomed Semantics (2014) 1.12
Structure of bacterial cellulose synthase subunit D octamer with four inner passageways. Proc Natl Acad Sci U S A (2010) 1.11
Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor. FEBS Lett (2007) 1.10
Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem (2002) 1.10
The carbohydrate sequence markup language (CabosML): an XML description of carbohydrate structures. Bioinformatics (2004) 1.10
Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules. Bioinformatics (2006) 1.09
A gram distribution kernel applied to glycan classification and motif extraction. Genome Inform (2006) 1.09
Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2. J Biol Chem (2002) 1.09
Structural basis for the recognition of Lewis antigens by genogroup I norovirus. J Virol (2012) 1.09
Normal embryonic and germ cell development in mice lacking alpha 1,3-fucosyltransferase IX (Fut9) which show disappearance of stage-specific embryonic antigen 1. Mol Cell Biol (2004) 1.08
Molecular cloning and characterization of a novel UDP-Gal:GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. J Biol Chem (2002) 1.08
Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int J Mol Med (2009) 1.08
N-Acetylglucosaminyltransferase IX acts on the GlcNAc beta 1,2-Man alpha 1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan. J Biol Chem (2003) 1.07
Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology (2009) 1.07
A role for Hrs in endosomal sorting of ligand-stimulated and unstimulated epidermal growth factor receptor. Exp Cell Res (2004) 1.07
Sorting of GPI-anchored proteins into ER exit sites by p24 proteins is dependent on remodeled GPI. J Cell Biol (2011) 1.06
The RINGS resource for glycome informatics analysis and data mining on the Web. OMICS (2010) 1.06
Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12. FEBS Lett (2002) 1.06
A strategy for identification of oligosaccharide structures using observational multistage mass spectral library. Anal Chem (2005) 1.06
Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase. J Biol Chem (2007) 1.06
Drug side-effect prediction based on the integration of chemical and biological spaces. J Chem Inf Model (2012) 1.05
Application of lectin microarray to crude samples: differential glycan profiling of lec mutants. J Biochem (2006) 1.05
Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice. Am J Pathol (2007) 1.05
A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J (2009) 1.05
Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem (2003) 1.05
Differential roles of two N-acetylgalactosaminyltransferases, CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2. Initiation and elongation in synthesis of chondroitin sulfate. J Biol Chem (2002) 1.04
A novel I-branching beta-1,6-N-acetylglucosaminyltransferase involved in human blood group I antigen expression. Blood (2002) 1.04
The DBCLS BioHackathon: standardization and interoperability for bioinformatics web services and workflows. The DBCLS BioHackathon Consortium*. J Biomed Semantics (2010) 1.04
Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver. Hepatol Res (2010) 1.01
Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology (2014) 1.01
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 is necessary for normal endochondral ossification and aggrecan metabolism. J Biol Chem (2010) 1.01
Alpha1,3-fucosyltransferase IX (Fut9) determines Lewis X expression in brain. Glycobiology (2003) 1.00
Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma. Int J Hematol (2008) 1.00
Experience of 100 surgical cases of encapsulating peritoneal sclerosis: investigation of recurrent cases after surgery. Adv Perit Dial (2006) 1.00